ENP Newswire -
Release date- 30052014 -
This bill is a model for legislation necessary in all 50 states to address this cutting-edge technology.
The policies outlined in Senate Substitute 1 for Senate Bill 118 align with all five of BIO's principles on biologic substitution. BIO and Delaware Bio furthermore commend
'This important legislation enjoys the support of physicians across the country, patient groups, and both biologic and biosimilar manufacturing companies,' said
Senate Substitute 1 for Senate Bill 118 seeks to properly preserve patient access to accurate prescription information, maintains incentives for innovation and promotes a competitive market for biologic therapies. BIO will continue to advocate for full transparency in the substitution process as patients and their physicians should have the right to know what biologic medicine the patient receives from the pharmacy.
'Interchangeable biologics are not generics. Even slight changes to a biologic drug can change its properties entirely,' said Greenwood. 'Unlike conventional generic medicines, interchangeable biologics are not the same as the drugs they seek to substitute. In fact, two biologics made using different cell lines and differing manufacturing processes will rarely, if ever, be exactly the same. Those suggesting interchangeable biologics and generics are the same are wrong.'
Patients and physicians managing chronic conditions are generally aware of which biologic treatments work best in their unique circumstances. Communicating with patients and physicians allows everyone involved the opportunity to discuss past treatment experiences so that any possible unexpected issues can be better understood and avoided.
As other states continue to address issues related to biologic substitution, BIO encourage policy makers to continue to put patients first.
About Delaware Bio
Delaware Bio is a non-profit trade association that serves its members and the
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across
BIO also produces the
Most Popular Stories
- Small-Business Loans Fueling Economic Growth
- Tesco Head Steps Down After Profit Warning
- Comic-Con Offers Toy Designers a Chance to Go Wild
- Google Chrome Bug Draining Batteries: Report
- Want a Job? Try Minneapolis
- Clinton Wants U.S., E.U. to Get Tough on Russia
- Startup Makes It Easier to Buy American
- BlackBerry Appoints New COO from LiveOps Inc.
- GM Looking for Ignition Fix for Certain Cadillacs
- U.S. Stocks Start the Week on Shaky Ground